Joseph C. Masdeu MD
Neuroimaging
"Graham Family Distinguished Chair for Neurological Sciences, Stanley H. Appel Department of Neurology Professor of Neurology, Institute for Academic Medicine Full Member, Research Institute Director, Nantz National Alzheimer Center Houston Methodist Weill Cornell Medical College"
Join to View Full Profile
6560 Fannin StreetSuite 750Houston, TX 77030
Phone+1 713-441-1150
Fax+1 713-790-4990
Dr. Masdeu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joseph Masdeu is a neurologist based in Houston, TX, with a subspecialty in neuroimaging. He completed his medical education at the Complutense University of Madrid, followed by an internship and residency in neurology at the Mount Sinai Hospital Medical Center of Chicago, and a fellowship in Neuropathology at Brigham and Women's in Boston. He has been chairman of Neurology at the New York Medical College and currently leads the Nantz National Alzheimer Center at Houston Methodist and is a professor of neurology at Weill Cornell Medicine. Dr. Masdeu has experience in Alzheimer's disease, and speech and language disorders. His recent publications include works on MRI and metabolism, neuroimaging biomarkers, Alzheimer's disease, and brain aging. He is also actively involved in clinical trials focused on Alzheimer's disease, psychosis by autoimmunity, and advanced MRI applications for brain injuries.
Education & Training
Rush University Medical CenterResidency, Neurology, 1974 - 1975
Loyola University Medical CenterResidency, Neurology, 1973 - 1973
Mount Sinai Hospital Medical Center of ChicagoInternship, Transitional Year, 1972 - 1973
Complutense University of MadridClass of 1969
Certifications & Licensure
TX State Medical License 2015 - 2026
NY State Medical License 1981 - 2020
IL State Medical License 1973 - 1984
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
Clinical Trials
- TBI MR Study 3 Houston Methodist Start of enrollment: 2014 Sep 01
- Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 Start of enrollment: 2015 Nov 01
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 1 citationsβ-Amyloid PET Signal Reduction in Prior ARIA-E Regions after Antiamyloid Therapy for Alzheimer Disease.Quentin Finn, Belen Pascual, Paul E Schulz, Joseph C Masdeu
AJNR. American Journal of Neuroradiology. 2026-04-23 - 2 citationsMapping the causal chain from genetic risk variants to lipid dysmetabolism in Parkinson's disease.Ruth B De-Paula, Jonggeol Kim, Herve Rhinn, Hiba Saade, Fatima Chavez
Brain. 2026-02-02 - Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.Konstantinos Chiotis, Ganna Blazhenets, David N Soleimani-Meigooni, Paul S Aisen, Alinda Amuiri
Medrxiv. 2026-01-26
Press Mentions
Novel PET Tracer Identifies Inflammation as Key Player in Alzheimer's DiseaseMarch 13th, 2025- Patrick Announces Texas Moonshot Program to Combat DementiaNovember 18th, 2024
COVID-19 Articles and ResourcesSeptember 23rd, 2020
Grant Support
- Glutathione, Brain Metabolism and Inflammation in Alzheimer's DiseaseBAYLOR COLLEGE OF MEDICINE2020–2026
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
